High-dose vaginal maintenance metronidazole for recurrent bacterial vaginosis: A pilot study

Sexually Transmitted Diseases

Volumn 41, Issue 5, 2014, Pages 290-291

  Aguin, Tina ^a   Akins, Robert A ^a   Sobel, Jack D ^b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; MICONAZOLE; ANTIINFECTIVE AGENT;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HUMAN; LOADING DRUG DOSE; MAINTENANCE THERAPY; PILOT STUDY; RECURRENT INFECTION; VAGINITIS; AFRICAN AMERICAN; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; INTRAVAGINAL DRUG ADMINISTRATION; MICROBIOLOGY; PATHOLOGY; SECONDARY PREVENTION; TREATMENT OUTCOME; UNITED STATES; VAGINA; VAGINOSIS, BACTERIAL; WOMEN'S HEALTH;

ADMINISTRATION, INTRAVAGINAL; ADULT; AFRICAN AMERICANS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; METRONIDAZOLE; PILOT PROJECTS; SECONDARY PREVENTION; TREATMENT OUTCOME; UNITED STATES; VAGINA; VAGINITIS; VAGINOSIS, BACTERIAL; WOMEN'S HEALTH;

EID: 84899104426     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000123     Document Type: Article

References (18)

1. Eschenbach DA. Bacterial vaginosis and anaerobes in obstetricgynecologicinfection. Clin Infect Dis 1993; 16:S282-S287.
2. Hillier S. The vaginal microbial ecosystem and resistance to HIV.AIDS Res Hum Retroviruses 1998; 14:17-21.
3. Fredricks DN, Fielder TL, Thomas KK, et al. Targeted PCR fordetection of vaginal bacteria associated with bacterial vaginosis. JClin Microbiol 2007; 45:3270-3276. (Pubitemid 47585650)
4. Livengood CH. Bacterial vaginosis: An overview for 2009. RevObstet Gynecol 2009; 2:28-37.
5. Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep 2000;2:506-512.
6. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence ratesof bacterial vaginosis over the course of 12 months after oral metronidazoletherapy and factors associated with recurrence. J InfectDis 2006; 193:1478-1486. (Pubitemid 43794575)
7. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect2004; 80:8-11. (Pubitemid 38221889)
8. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterialtherapy with 0.75% metronidazole vaginal gel to prevent recurrentbacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-1289.
9. Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterialvaginosis with tinidazole. Obstet Gynecol 2004; 104:931-932.
10. Greaves WL, Chungafung J, Morris B, et al. Clindamycin versusmetronidazole in the treatment of bacterial vaginosis. Obstet Gynecol1988; 72:799-802.
11. Koumans EH, Markowitz LE, Hogan V. Indications for therapy andtreatment recommendations for bacterial vaginosis in nonpregnantand pregnant women: A synthesis of data. Clin Infect Dis 2002;35:S152-S172. (Pubitemid 35178327)
12. Aguin TA, Akins RA, Sobel JD. High-dose vaginal metronidazolefor recurrent bacterial vaginosisVA pilot study. J Low Genit TractDis 2013. [Epub ahead of print].
13. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterialvaginosis is improved by a standardization method of Gramstain interpretation. J Clin Microbiol 1991; 29:297-301.
14. Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: Review oftreatment options and potential clinical indications for therapy. ClinInfect Dis 1999; 28:S57-S65. (Pubitemid 29249961)
15. Paavonen J, Mangioni C, Martin MA, et al. Vaginal clindamycinand oral metronidazole for bacterial vaginosis. Obstet Gynecol2000; 96:256-260. (Pubitemid 30447349)
16. Hillier SL, Lipinski C, Briselden AM, et al. Efficacy of intravaginal0.75% metronidazole gel for the treatment of bacterial vaginosis.Obstet Gynecol 1993; 81:963-967. (Pubitemid 23168742)
17. Sobel JD, Schmitt C, Meriwether C. Long-term follow-up of patientswith bacterial vaginosis treated with oral metronidazole andtopical clindamycin. J Infect Dis 1993; 167:783-784. (Pubitemid 23056363)
18. Reichman O, Akins R, Sobel JD. Boric acid addition to suppressiveantimicrobial therapy for recurrent bacterial vaginosis. Sex TransmDis 2009; 36:732-734.